FDA Inspection 1198346 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3008629223

The FDA completed an inspection of Oklahoma Blood Institute on February 3, 2023 in Hot Springs, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 3, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hot Springs, AR (United States)